Bacteriostatic Water · 10 mLIDR 69.600RESEARCH PEPTIDE
Tirzepatide 10 mg

Tirzepatide 10 mg
Tirzepatide is a dual GIP/GLP-1 receptor agonist studied for coordinated incretin signalling and glucose-dependent metabolic pathways.
About this research category
Dual GIP/GLP-1 receptor research. Evidence for a studied medicinal formulation does not establish this research vial as an approved or safe treatment.
Labels describe study topics - not proven benefits, personal-use guidance or product compatibility.
Read the primary study ↗
Quality documentation
Janoshik COA Available
View the supplied Janoshik report for Tirzepatide 10 mg. Results relate to the sample identified in the report.
IDR 887.900
Line total: IDR 887.900
Available from local Bali stock
Eligible in-stock orders confirmed before 5 PM Bali time can receive same-day dispatch, subject to order confirmation and fulfilment arrangements.
Gojek delivery is arranged to your hotel, villa or other Bali destination. Confirm the address, receiving contact and handover window with the team in WhatsApp.
Check Bali delivery areas: Canggu, Seminyak, Ubud & wider Bali →For laboratory and scientific research only · not for human consumption.
Laboratory supplies
Need bacteriostatic water?
Add BAC water to your order if required by your laboratory protocol. Choose the size below; compatibility depends on your research requirements.
Compare bacteriostatic water in Bali: 3 mL & 10 mL →
Bacteriostatic Water · 10 mLIDR 69.600
Bacteriostatic Water · 3 mLIDR 40.000Optional add-on, not added automatically. BAC water does not count towards the peptide-vial discount threshold.
Explore more research materials
Other listings in this category - not a recommendation to combine products.
Tirzepatide · 20 mgIDR 1.775.500Research categoryIncretin signalling research
AOD-9604 · 10 mgIDR 2.530.000Research categoryLipid-metabolism research- Product
- Tirzepatide
- Strength
- 10 mg
- Category
- Research Peptides
- Purity
- ≥99.6% PURITY
- Use
- Laboratory and scientific research only
- Price
- IDR 887.900
- Availability
- 7 in stock
The power of dual-incretin receptor research.
Tirzepatide is a dual GIP/GLP-1 receptor agonist studied for coordinated incretin signalling and glucose-dependent metabolic pathways.
Research context
Preclinical characterisation examines coordinated GIP and GLP-1 receptor agonism, downstream cAMP signalling, and glucose-dependent metabolic responses. This mechanism-led profile does not promise weight-loss, glycaemic, appetite, or cardiovascular outcomes.
Research interests
- GIP receptor signalling
- GLP-1 receptor signalling
- Glucose-dependent metabolic pathways


